Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: A review
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Le Houezec (2003)
Safety Profile of a Nicotine Lozenge Compared with That_x000D_of Nicotine Gum in Adult Smokers with Underlying Medical_x000D_Conditions: A 12-Week, Randomized, Open-Label Study
Individual Clinical
Safety
Adverse Effects
Marsh et al (2005)
Effects of nicotine administration via a sublingual tablet on arousal and verbal ability in non-smokers
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of Users
Neumann (2009)
Nicorette Microtab 2mg Sublingual Tablet Nicotine
General
Industry Information
Market Availability
McNeil products Ltd. (2021)
Local Tolerance of a Sublingual Nicotine Tablet, an Open Single-Centre Study
Individual Clinical
Safety
Human Factors
Sand et al (2012)
Efficacy of a Nicotine Lozenge for Smoking Cessation
Population Clinical
Cessation
Tobacco Cessation
Shiffman et al (2002)
Smoking Cessation: What to Tell patients About Over-the-Counter Treatments
General
Burghardt and Ellingrod (2012)
Randomized Comparative Trial of Nicotine Polacrilex, a Transdermal Patch, Nasal Spray, and an Inhaler.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Hajek et al (1999)
Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review.
Individual Clinical
West and Shiffman (2001)
Identification and Quantitation of Nicotine Polacrilex in Nicotine Pouches and Other Oral Nicotine Delivery Products
Non-Clinical
Chemical
Analysis
Moldoveanu (2023)